HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
3 hedge funds and large institutions have $8.61M invested in Hepion Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
-3
Holders Change %
-50%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$907K |
Top Sellers
| 1 |
TCIM
TIAA CREF Investment Management
New York
|
-$4.41M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
-$3.4M |
| 3 |
TA
Teachers Advisors
New York
|
-$1.82M |
| 4 |
Morgan Stanley
New York
|
-$333K |
| 5 |
JPMorgan Chase & Co
New York
|
-$240K |
